Medicl Device Network@2x
Device Development Opthalmic

Sections

  • Diagnostics
  • Imaging
  • Monitoring
  • Manufacturing
  • Materials
  • Treatments
  • Device Development
    • Anesthesia & Respiratory
    • Cardiovascular
    • Dental
    • Diabetes Care
    • Nephrology & Urology
    • Neurology
    • Opthalmic
    • Orthopedic

Most Read

  • Topcon launches Aladdin-M myopia management system in US
  • Sight Sciences enrols first patients in OMNI Surgical System trial
  • Eye on the prize: ophthalmology’s digital future

Most Recent

Device Development

Topcon launches Aladdin-M myopia management system in US

31 Aug 2020
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Diagnostics
    • Imaging
    • Monitoring
    • Manufacturing
    • Materials
    • Treatments
    • Device Development
      • Anesthesia & Respiratory
      • Cardiovascular
      • Dental
      • Diabetes Care
      • Nephrology & Urology
      • Neurology
      • Opthalmic
      • Orthopedic
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Precision medical wire
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Device Development Opthalmic

Sections

  • Diagnostics
  • Imaging
  • Monitoring
  • Manufacturing
  • Materials
  • Treatments
  • Device Development
    • Anesthesia & Respiratory
    • Cardiovascular
    • Dental
    • Diabetes Care
    • Nephrology & Urology
    • Neurology
    • Opthalmic
    • Orthopedic

Most Read

  • Topcon launches Aladdin-M myopia management system in US
  • Sight Sciences enrols first patients in OMNI Surgical System trial
  • Eye on the prize: ophthalmology’s digital future

Most Recent

Device Development

Topcon launches Aladdin-M myopia management system in US

31 Aug 2020
Latest Opthalmic
  • Topcon launches Aladdin-M myopia management system in US
    5 months
  • Sight Sciences enrols first patients in OMNI Surgical System trial
    5 months
  • Eye on the prize: ophthalmology’s digital future
    7 months
  • 3D visualisation tech launched for UK cancer patients
    11 months
  • Topcon launches Aladdin-M myopia management system in US
    5 months
  • Sight Sciences enrols first patients in OMNI Surgical System trial
    5 months
  • Eye on the prize: ophthalmology’s digital future
    7 months
  • 3D visualisation tech launched for UK cancer patients
    11 months
Topcon launches Aladdin-M myopia management system in US
Device Development

Topcon launches Aladdin-M myopia management system in US

Japan-based ophthalmology medical devices and software solutions provider Topcon Healthcare has launched its new Aladdin-M system to the US market.…

31 Aug 2020

Top 5 Most Read

Analysis 10 hours

Scotland: towards a med tech manufacturing powerhouse

1
Deals Analysis 1 day

Hologic kicks off 2021 with acquisitions in breast cancer market

2
Analysis 4 days

All the feels: advances in measuring human emotion

3
Analysis 5 days

Medical device approvals: FDA takes a STeP in the right direction

4
News 6 days

Valencell blood pressure tech expands to finger and wrist wearables

5

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
medical device

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more